Pesquisar | MTSocial

Shubhangi Fusam adicionou um novo artigo Health
2025-11-18 11:20:27 -

Beyond Off-Target Effects: How Base Editing and Prime Editing are Redefining Precision and Unlocking New Opportunities in the Gene Editing Market.
While CRISPR/Cas9 revolutionized molecular biology, its mechanism—creating a double-strand break (DSB) in the DNA—carries inherent risks, including potential off-target edits at unintended genomic locations and unpredictable repair outcomes that can lead to large deletions or translocations. This safety concern has been a major point of regulatory scrutiny and a limit to its broader...

0 Comentários 0 Compartilhamentos 51 Visualizações 0 Anterior

Faça Login para curtir, compartilhar e comentar!
Shubhangi Fusam adicionou um novo artigo Health
2025-11-19 12:16:57 -

From Lab Bench to Bedside: Tracing the Ascent of Gene Therapy Applications as the Fastest-Growing Segment in Genetic Engineering.
The gene editing market is fundamentally partitioned by application, where one segment represents the foundational tools of research and industry, and the other represents the cutting edge of clinical care. Genetic engineering, which encompasses the use of gene editing for basic biological research, creating model organisms, and developing highly specialized cell lines for drug manufacturing,...

0 Comentários 0 Compartilhamentos 17 Visualizações 0 Anterior

Faça Login para curtir, compartilhar e comentar!
Pratiksha Dhote adicionou um novo artigo Health
2025-11-20 10:47:21 -

From Lab Bench to Clinic: Tracking the Rapid Translation of Gene Editing Tools into Commercialized Disease Treatments
While the therapeutic applications of gene editing in human medicine garner the most attention, the market’s enormous commercial potential is significantly bolstered by its diverse applications in other sectors, particularly agriculture and industrial biotechnology. In agriculture, gene editing tools are being used to rapidly and precisely enhance crop traits, such as increasing yield,...

0 Comentários 0 Compartilhamentos 9 Visualizações 0 Anterior

Faça Login para curtir, compartilhar e comentar!